Vaxess Technologies
Pagliuca Harvard Life Lab
Vaxess Technologies
Developing a novel transdermal patch technology to transform home delivery of therapies and vaccines
About Vaxess Technologies
School
Harvard Law School, Harvard Extension School, Harvard Business School, Harvard Kennedy School
Connect
Awards & Affiliations
More Pagliuca Harvard Life Lab Ventures
-
Nucyrna Therapeutics
Nucyrna Therapeutics aims to redefine RNA-targeting therapeutics, starting in neurodegenerative diseases.
![Nucyrna team lead]()
-
Tectonic Therapeutic, Inc.
Transforming the discovery of novel drugs addressing targets in the GPCR family.
![Tectonic team]()
-
Manifold Bio
Designing tissue-specific medicines in living systems from the start by combining high-throughput in-vivo studies with AI-guided protein design.
![Manifold team]()
Join The Life Lab
The Life Lab is proud to support high-potential biotech and life-science ventures led by a Harvard affiliate.
